QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

• 收藏
• 分享

专利权人:

ABBVIE DEUTSCHLAND GMBH & CO KG

发明人:

TURNER SEAN COLM,BRAJE WILFRIED MARTIN,HAUPT ANDREAS,LANGE UDO,DRESCHER KARLA,WICKE KARSTEN,UNGER LILIANE,MEZLER MARIO,WERNET WOLFGANG,MAYRER MATTHIAS

申请号：

ZA200909075

公开号：

ZA200909075B

申请日:

2009.12.18

申请国别(地区):

ZA

年份:

2013

代理人:

摘要：

The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. In formula (I) R is a moiety of the formula (R) wherein * indicates the binding site to the quinolinyl radical and wherein A, B, X&prime；, Y, Q, R1, R2, R3, R4, R5, m, n, p, q, Ra, Rb, X and Ar are as defined in claim 1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/